References
- PiCWeiYYangHDevelopment of a HPLC method to determine 5-fluorouracil in plasma: application in pharmacokinetics and steady-state concentration monitoringInt J Clin Pharmacol Ther201452121093110125161161
- MuzzalupoRTavanoLRossiCOPicciNRanieriGANovel pH sensitive ferrogels as new approach in cancer treatment: effect of the magnetic field on swelling and drug deliveryColloids Surf B Biointerfaces201513427327826209777
- OtsuboDYamashitaKFujitaMEarly-phase treatment by low-dose 5-fluorouracil or primary tumor resection inhibits MDSC-mediated lung metastasis formationAnticancer Res20153584425443126168482
- XuZYTangJNXieHX5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cellsInt J Biol Sci201511328429425678847
- ZhangXQZhangHMSunXEYuanZJFengYGInhibitory effects and mechanism of 5-fluorouracil combined with celecoxib on human gastric cancer xenografts in nude miceExp Ther Med20159110511125452783
- TummalaSSatish KumarMNPrakashAFormulation and characterization of 5-fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancerSaudi Pharm J201523330831426106279
- WangTHuangBGuoRA let-7b binding site SNP in the 3′-UTR of the Bcl-xL gene enhances resistance to 5-fluorouracil and doxorubicin in breast cancer cellsOncol Lett2015941907191125789066
- NousoKMiyaharaKUchidaDLiver Cancer Study Group of JapanEffect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in JapanBr J Cancer201310971904190724008659
- UchiharaTYamashitaYHualinWRecurrence 11 years after complete response to gemcitabine, 5-Fluorouracil, and Cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: a case reportAnticancer Res20153552867287125964569
- Shakeri-ZadehAShiranMBKhoeeSSharifiAMGhaznaviHKhoeiSA new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft modelJ Biomater Appl201429454855624913615
- ZhouZCaoDLiuLFabrication and properties of gelatin/chitosan microspheres loaded with 5-fluorouracilJ Macromol Sci B2013527/9973983
- LiXXuYChenGPLGA nanoparticles for the oral delivery of 5-fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studiesDrug Dev Ind Pharm200834110711518214762
- Farshi AzharFOladAA study on sustained release formulations for oral delivery of 5-fluorouracil based on alginate-chitosan/montmorillonite nanocomposite systemsAppl Clay Sci2014101288296
- VaghaniSVasantiSChaturvediKSatishCSJivaniNPStomach-specific drug delivery of 5-fluorouracil using ethylcellulose floating microspheresPharm Dev Technol201015215416120214502
- SoppimathKSKulkarniARAminabhaviTMDevelopment of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristicsDrug Dev Ind Pharm200127650751511548857
- Ruiz-CaroRGago-GuillanMOtero-EspinarFJVeigaMDMucoad-hesive tablets for controlled release of acyclovirChem Pharm Bull (Tokyo)201260101249125722863800
- HouJYGaoLNMengFYCuiYLMucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluationMar Drugs201412125764578725470180
- StreubelASiepmannJBodmeierRGastroretentive drug delivery systemsExpert Opin Drug Deliv20063221723316506949
- El-ZahabySAKassemAAEl-KamelAHFormulation and in vitro evaluation of size expanding gastro-retentive systems of levofloxacin hemihydrateInt J Pharm20144641–2101824472642
- ChenRNHoHOYuCYSheuMTDevelopment of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphismEur J Pharm Sci2010391–3828919903527
- HaoSWangBWangYDensity-dependent gastroretentive microparticles motion in human gastric emptying studied using computer simulationEur J Pharm Sci201570728125640913
- SvirskisDSeyfoddinAChaplainSDevelopment of mucoadhesive floating hollow beads of acyclovir with gastroretentive propertiesPharm Dev Technol201419557157623859639
- KotrekaUKAdeyeyeMCGastroretentive floating drug-delivery systems: a critical reviewCrit Rev Ther Drug Carrier Syst2011281479921395515
- El-GibalyIDevelopment and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheresInt J Pharm20022491–272112433430
- KawashimaYNiwaTTakeuchiHHinoTItohYHollow micro-spheres for use as a floating controlled drug delivery system in the stomachJ Pharm Sci19928121351401372046
- ZhaoLWeiYMYuYZhengWWPolymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: in vitro evaluationArch Pharm Res201033344345020361310
- DubeTSRanpiseNSRanadeANFormulation and evaluation of gastroretentive microballoons containing baclofen for a floating oral controlled drug delivery systemCurr Drug Deliv201411680581624730440
- WeiYMZhaoLIn vitro and in vivo evaluation of ranitidine hydrochloride loaded hollow microspheres in rabbitsArch Pharm Res200831101369137718958430
- WeiYMZhaoLYuMAPreparation of oral hollow microsphere carriersChinese Patent numberZL200610095105.5200696
- StithitSChenWPriceJCDevelopment and characterization of buoyant theophylline microspheres with near zero order release kineticsJ Microencapsul19981567257379818950
- Pharmacopoeia of the People’s Republic of ChinaBeijingChemical Industry Publishing House2010
- BhosaleUVDeviKChoudharySMultiunit floating drug delivery system of acyclovir: development, characterization and in vitro-in vivo evaluation of spray-dried hollow microspheresJ Drug Del Sci Tech2012226548554
- SatoYKawashimaYTakeuchiHYamamotoHFujibayashiYPharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humansJ Control Release2004981758515245891